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Other names: CAN; CAIN; D9S46E; NUP214 
(nuclear pore complex protein 214 kDa) 
Location: 9q34.3 
Local order: from centromere to telomere: SET, 




NUP214 (9q34.3) - Courtesy Mariano Rocchi, Resources for 
Molecular Cytogenetics.  
DNA/RNA 
Description 
36 exons encompassing about 108 kb of genomic 
DNA. 
Transcription 
6.6 kb mRNA. 
Protein 
Description 
2090 amino acids; 214 kDa; dimerization domains (2 
leucine zippers) and FG repeats; forms homodimers. 
Expression 
Thymus, bone marrow, spleen, kidney, testis, brain; 
apparently not in other tissues. 
Localisation 
Nuclear membrane; cytoplasmic face of nucleopore. 
Function 
Nucleoporins are the main components of 
the../Deep/NuclearPoreComplID20048.html Nuclear 
pore complex(NPC) in eukaryotic cells. The nuclear 
pore complex is a massive structure that extends across 
the nuclear envelope, forming a gateway that regulates 
the flow of macromolecules between the nucleus and 
the cytoplasm. NUP214 may serve as a docking site in 
the receptor mediated import of substrates across the 
NPC, and plays a role in nuclear protein import, mRNA 
export, and cell cycle progression; interacts with 
DDX19, NUP88, and XPO1. 
Homology 
NUP214 is a member of the FG-repeat-containing 
nucleoporins. 
Implicated in 
t(6;9)(p23;q34) → DEK-NUP214 
Disease 
M2, M4 ANLL or MDS. 
Prognosis 
Remission difficult to obtain. 
Cytogenetics 
This chromosome anomaly may be over looked. 
Hybrid/Mutated Gene 
5' DEK - 3' NUP214; chromosome 6 breakpoint 
clusters in a single intron. 
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Abnormal Protein 
Head to tail DEK/NUP214 fusion protein (the 
alternative SET/NUP214 is exceptional); almost the 
entire DEK protein is fused to the C-terminal two-
thirds of the NUP214 protein; nuclear localization. 
t(9;9)(q34;q34) /AUL → SET-NUP214 
Note: the only SET-NUP214 positive case described so 
far had a normal karyotype; on the cytogenetic level it 
is unclear whether the SET-NUP214 fusion is 
generated by a t(9;9)(q34;q34) or an interstitial deletion 
at 9q34; the latter is supported by the centromere-
telomere orientation of both genes and their local rder: 
centromere ' SET - NUP214' telomere. 
Disease 
Only one case to date; acute undifferentiated leukemia. 
Cytogenetics 
May be overlooked. 
Hybrid/Mutated Gene 
5' SET - 3' NUP214 
Amplification → NUP214- ABL1 
Disease 
5-6% of childhood and adult T-ALL. 
Prognosis 
Aggressive course of disease. 
Cytogenetics 
Found in T-ALL with various karyotypes. 
Hybrid/Mutated Gene 
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